Jeil Pharma Holdings Inc. operates as a pharmaceutical manufacturing company. The Company manufactures analgesic anti-inflammatories, broad-spectrum oral antimicrobial agents, analgesic anti-cold poultice poultices, hyperlipidemia agents, intravenous antibiotics, and other products. Jeil Pharma Holdings markets its products throughout Korea.

Details of Corporate Governance Report (2024.12)

Outcome of Annual Shareholders' Meeting

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Jeil Pharma Holdings (002620 KS)

Details of Corporate Governance Report (2024.12)

Outcome of Annual Shareholders' Meeting

Submission of Audit Report

Decision on Calling Shareholders' Meeting

Decision on Cash Dividends and Dividends in Kind

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)